Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.

Michels MAHM, van de Kar NCAJ, van den Bos RM, van der Velden TJAM, van Kraaij SAW, Sarlea SA, Gracchi V, Oosterveld MJS, Volokhina EB, van den Heuvel LPWJ.

Front Immunol. 2019 Jun 17;10:1350. doi: 10.3389/fimmu.2019.01350. eCollection 2019.

2.

Multiplex Label Free Characterization of Cancer Cell Lines Using Surface Plasmon Resonance Imaging.

Stojanović I, Ruivo CF, van der Velden TJG, Schasfoort RBM, Terstappen LWMM.

Biosensors (Basel). 2019 May 27;9(2). pii: E70. doi: 10.3390/bios9020070.

3.

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.

Pediatr Nephrol. 2017 Feb;32(2):297-309. doi: 10.1007/s00467-016-3496-0. Epub 2016 Oct 7.

4.

Modeling single cell antibody excretion on a biosensor.

Stojanović I, Baumgartner W, van der Velden TJ, Terstappen LW, Schasfoort RB.

Anal Biochem. 2016 Jul 1;504:1-3. doi: 10.1016/j.ab.2016.03.018. Epub 2016 Mar 31.

PMID:
27040182
5.

Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Volokhina EB, van de Kar NC, Bergseth G, van der Velden TJ, Westra D, Wetzels JF, van den Heuvel LP, Mollnes TE.

Clin Immunol. 2015 Oct;160(2):237-43. doi: 10.1016/j.clim.2015.05.018. Epub 2015 Jun 23.

6.

Quantification of antibody production of individual hybridoma cells by surface plasmon resonance imaging.

Stojanović I, van der Velden TJ, Mulder HW, Schasfoort RB, Terstappen LW.

Anal Biochem. 2015 Sep 15;485:112-8. doi: 10.1016/j.ab.2015.06.018. Epub 2015 Jun 18.

PMID:
26095397
7.

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.

Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP.

Clin Exp Immunol. 2015 Aug;181(2):306-13. doi: 10.1111/cei.12426.

8.

Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells.

Wilmer MJ, Kluijtmans LA, van der Velden TJ, Willems PH, Scheffer PG, Masereeuw R, Monnens LA, van den Heuvel LP, Levtchenko EN.

Biochim Biophys Acta. 2011 Jun;1812(6):643-51. doi: 10.1016/j.bbadis.2011.02.010. Epub 2011 Feb 28.

9.

Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters.

Wilmer MJ, Saleem MA, Masereeuw R, Ni L, van der Velden TJ, Russel FG, Mathieson PW, Monnens LA, van den Heuvel LP, Levtchenko EN.

Cell Tissue Res. 2010 Feb;339(2):449-57. doi: 10.1007/s00441-009-0882-y. Epub 2009 Nov 10.

10.

Interactions of Shiga-like toxin with human peripheral blood monocytes.

Geelen JM, van der Velden TJ, van den Heuvel LP, Monnens LA.

Pediatr Nephrol. 2007 Aug;22(8):1181-7. Epub 2007 May 22.

11.

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.

Geelen JM, van der Velden TJ, Te Loo DM, Boerman OC, van den Heuvel LP, Monnens LA.

Nephrol Dial Transplant. 2007 Mar;22(3):749-55. Epub 2006 Nov 24.

PMID:
17127697
12.

Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome.

Fernández GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL.

Pediatr Nephrol. 2003 Oct;18(10):1066-8. Epub 2003 Aug 12.

PMID:
12920633
13.

Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.

te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW.

Blood. 2000 Jun 1;95(11):3396-402.

PMID:
10828021
14.

Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.

Heuvelink AE, Van de Kar NC, Van Der Velden TJ, Chart H, Monnens LA.

Pediatr Infect Dis J. 1999 Aug;18(8):709-14.

PMID:
10462341
15.

Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.

van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA.

Pediatr Res. 1998 Jun;43(6):759-67.

PMID:
9621985
16.

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.

Van Setten PA, van Hinsbergh VW, Van den Heuvel LP, van der Velden TJ, van de Kar NC, Krebbers RJ, Karmali MA, Monnens LA.

J Am Soc Nephrol. 1997 Dec;8(12):1877-88.

17.

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA.

Kidney Int. 1997 Apr;51(4):1245-56.

18.

Binding of the cage convulsant, [3H]TBOB, to sites linked to the GABAA receptor complex.

Van Rijn CM, Willems-van Bree E, Van der Velden TJ, Rodrigues de Miranda JF.

Eur J Pharmacol. 1990 Apr 25;179(3):419-25.

PMID:
2163855
19.

Folates: epileptogenic effects and enhancing effects on [3H]TBOB binding to the GABAA-receptor complex.

Van Rijn CM, Van der Velden TJ, Rodrigues de Miranda JF, Feenstra MG, Hiel JA, Hommes OR.

Epilepsy Res. 1990 Apr;5(3):199-208.

PMID:
2166659
20.

The influence of folic acid on the picrotoxin-sensitive site of the GABAa-receptor complex.

Van Rijn CM, Van der Velden TJ, Rodrigues de Miranda JF, Feenstra MG, Hommes OR.

Epilepsy Res. 1988 May-Jun;2(3):215-8.

PMID:
2848698

Supplemental Content

Loading ...
Support Center